D-Index & Metrics Best Publications
Frans M.J. Debruyne

Frans M.J. Debruyne

Medicine
Belgium
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 89 Citations 29,058 718 World Ranking 8008 National Ranking 88

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Belgium Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

Prostate, Surgery, Urology, Pathology and Prostate cancer are his primary areas of study. His research in Prostate focuses on subjects like Hyperplasia, which are connected to Adenoma. His work deals with themes such as Internal medicine, Carcinoma and Transurethral microwave thermotherapy, which intersect with Surgery.

His Urology research integrates issues from Lower urinary tract symptoms, Randomized controlled trial, Antiandrogen and Urinary system. His study in Pathology is interdisciplinary in nature, drawing from both Cancer, Cancer research, Cadherin and Cellular differentiation. His Prostate cancer research includes themes of High-mobility group, Magnetic resonance imaging and In situ hybridization.

His most cited work include:

  • DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer (884 citations)
  • Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. (568 citations)
  • Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. (565 citations)

What are the main themes of his work throughout his whole career to date?

Frans M.J. Debruyne mainly focuses on Surgery, Urology, Prostate, Internal medicine and Pathology. His work on Surgery is being expanded to include thematically relevant topics such as Bladder outlet obstruction. In the field of Urology, his study on Urinary bladder overlaps with subjects such as In patient.

Frans M.J. Debruyne combines subjects such as Radiology, Prostate cancer and Hyperplasia with his study of Prostate. The various areas that Frans M.J. Debruyne examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology. His Pathology research is multidisciplinary, incorporating elements of Cancer, Cancer research and Antibody.

He most often published in these fields:

  • Surgery (32.23%)
  • Urology (25.64%)
  • Prostate (20.77%)

What were the highlights of his more recent work (between 2001-2021)?

  • Surgery (32.23%)
  • Urology (25.64%)
  • Internal medicine (18.48%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Surgery, Urology, Internal medicine, Prostate cancer and Prostate. He works on Surgery which deals in particular with Randomized controlled trial. His work carried out in the field of Urology brings together such families of science as Lower urinary tract symptoms, Quality of life, Urinary system, Randomization and Prostate-specific antigen.

His research in Internal medicine intersects with topics in Endocrinology and Oncology. His Prostate cancer study integrates concerns from other disciplines, such as Clinical trial and Zoledronic acid. Frans M.J. Debruyne is interested in International Prostate Symptom Score, which is a branch of Prostate.

Between 2001 and 2021, his most popular works were:

  • Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study. (207 citations)
  • Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia (199 citations)
  • Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial (154 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Surgery
  • Cancer

His primary areas of investigation include Surgery, Urology, Internal medicine, Quality of life and Tibial nerve. His Surgery study incorporates themes from Prostatectomy and General surgery. His Urology research incorporates elements of Lower urinary tract symptoms, Prostate, Urinary system, Randomization and Watchful waiting.

His Prostate research is multidisciplinary, relying on both Biopsy, Magnetic resonance imaging, Prostate cancer and Hazard ratio. His work on Nephrology, Erectile dysfunction, Randomized controlled trial and Gonadotropin-releasing hormone antagonist as part of general Internal medicine study is frequently linked to Vardenafil, therefore connecting diverse disciplines of science. He has included themes like Urination and Anesthesia in his Tibial nerve study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer

M.J.G. Bussemakers;A. van Bokhoven;G.W.C.T. Verhaegh;F.P. Smit.
Cancer Research (1999)

1412 Citations

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Donald L. Lamm;Ad P.M. Van Der Meijden;Alvaro Morales;Stanley A. Brosman.
The Journal of Urology (1992)

872 Citations

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Umbas R;Schalken Ja;Aalders Tw;Carter Bs.
Cancer Research (1992)

818 Citations

Decreased E-Cadherin Expression Is Associated with Poor Prognosis in Patients with Prostate Cancer

R. Umbas;W. B. Isaacs;P. P. Bringuier;H. E. Schaafsma.
Cancer Research (1994)

706 Citations

Decreased E-Cadherin Immunoreactivity Correlates with Poor Survival in Patients with Bladder Tumors

P. P. Bringuier;R. Umbas;H. E. Schaafsma;H. F. M. Karthaus.
Cancer Research (1993)

516 Citations

Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.

Marloes van der Leest;Erik Cornel;Bas Israël;Rianne Hendriks.
European Urology (2019)

507 Citations

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

Frans Debruyne;Gary Koch;Peter Boyle;Fernando Calais Da Silva.
European Urology (2002)

334 Citations

4–Year Follow–Up Results of a European Prospective Randomized Study on Neoadjuvant Hormonal Therapy prior to Radical Prostatectomy in T2–3N0M0 Prostate Cancer

Claude C. Schulman;Frans M.J. Debruyne;Gerhard Forster;Francesco P. Selvaggi.
European Urology (2000)

331 Citations

Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.

Toru Shimazui;Jack A. Schalken;Laurence A. Giroldi;Cornelius F. J. Jansen.
Cancer Research (1996)

308 Citations

Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia

Frans Debruyne;Jack Barkin;Peter van Erps;Mario Reis.
European Urology (2004)

308 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Frans M.J. Debruyne

Jack A. Schalken

Jack A. Schalken

Radboud University Nijmegen

Publications: 104

Claus G. Roehrborn

Claus G. Roehrborn

The University of Texas Southwestern Medical Center

Publications: 69

Peter F.A. Mulders

Peter F.A. Mulders

Radboud University Nijmegen

Publications: 64

J. Alfred Witjes

J. Alfred Witjes

Radboud University Nijmegen

Publications: 59

Michael Marberger

Michael Marberger

Medical University of Vienna

Publications: 57

Jean J.M.C.H. de la Rosette

Jean J.M.C.H. de la Rosette

Istanbul Medipol University

Publications: 56

Hashim U. Ahmed

Hashim U. Ahmed

Imperial College Healthcare NHS Trust

Publications: 50

Lambertus A. Kiemeney

Lambertus A. Kiemeney

Radboud University Nijmegen

Publications: 46

Liang Cheng

Liang Cheng

Indiana University

Publications: 43

Mark Emberton

Mark Emberton

University College London

Publications: 42

Rodolfo Montironi

Rodolfo Montironi

Marche Polytechnic University

Publications: 41

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 40

Fritz H. Schröder

Fritz H. Schröder

Erasmus MC

Publications: 39

Otto C. Boerman

Otto C. Boerman

Radboud University Nijmegen

Publications: 38

Arul M. Chinnaiyan

Arul M. Chinnaiyan

University of Michigan–Ann Arbor

Publications: 38

Alfredo Fusco

Alfredo Fusco

University of Naples Federico II

Publications: 38

Trending Scientists

Susan J. Eggers

Susan J. Eggers

University of Washington

Vincent Ng

Vincent Ng

The University of Texas at Dallas

Thomas A. Manteuffel

Thomas A. Manteuffel

University of Colorado Boulder

Haiyan Lu

Haiyan Lu

University of Technology Sydney

Edward O. Edney

Edward O. Edney

Environmental Protection Agency

Yoshihisa Takaishi

Yoshihisa Takaishi

University of Tokushima

Takayuki Kurokawa

Takayuki Kurokawa

Hokkaido University

Masaki Fukata

Masaki Fukata

The Graduate University for Advanced Studies, SOKENDAI

Alexandra M. E. Jones

Alexandra M. E. Jones

University of Warwick

Yosef Yarom

Yosef Yarom

Hebrew University of Jerusalem

Felipe González Castro

Felipe González Castro

Arizona State University

Marco J. Bruno

Marco J. Bruno

Erasmus University Rotterdam

Werner Poewe

Werner Poewe

Innsbruck Medical University

Scott Lash

Scott Lash

University of Oxford

Irene H. Yen

Irene H. Yen

University of California, Merced

Stephen Drinkwater

Stephen Drinkwater

University of Roehampton

Something went wrong. Please try again later.